176 related articles for article (PubMed ID: 36177767)
1. Monitoring oral propranolol for infantile hemangiomata.
Bar J; Bar-Ilan E; Cleper R; Sprecher E; Samuelov L; Mashiah J
Dermatol Ther; 2022 Nov; 35(11):e15870. PubMed ID: 36177767
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and blood glucose parameters in infants during propranolol initiation for treatment of symptomatic infantile hemangiomas.
Puttgen KB; Summerer B; Schneider J; Cohen BA; Boss EF; Bauman NM
Ann Otol Rhinol Laryngol; 2013 Sep; 122(9):550-4. PubMed ID: 24224397
[TBL] [Abstract][Full Text] [Related]
3. Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma.
Püttgen KB; Hansen LM; Lauren C; Stefanko N; Mathes E; Olsen GM; Tollefson MM; Adams D; Baselga E; Chamlin S; Corey K; Frascari FF; Frieden IJ; Galligan ER; Gupta D; Haggstrom A; Horii K; Hornik CP; Klajn J; Liberman L; Mancini A; Mannschreck D; McGinness A; McCuaig C; Newell B; Nguyen H; Nopper A; Oyesanya T; Powell J; Reynolds M; Rios M; Siegel DH; Ward K; Garzon MC; Frommelt P; Drolet BA
J Am Acad Dermatol; 2021 Aug; 85(2):345-352. PubMed ID: 32289387
[TBL] [Abstract][Full Text] [Related]
4. Safety profile during initiation of propranolol for treatment of infantile haemangiomas in an ambulatory day-care hospitalization setting.
Fogel I; Ollech A; Zvulunov A; Valdman-Greenshpon Y; Atar Snir V; Friedland R; Lapidoth M; Ben-Amitai D
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):2004-2009. PubMed ID: 29573481
[TBL] [Abstract][Full Text] [Related]
5. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a modified outpatient model for using propranolol to treat infantile hemangiomas.
Putterman E; Wan J; Streicher JL; Yan AC
Pediatr Dermatol; 2019 Jul; 36(4):471-476. PubMed ID: 31120143
[TBL] [Abstract][Full Text] [Related]
7. Cardiac side effects of propranolol in infants treated for infantile haemangiomas.
Maliqari N; Duka E; Kuneshka L
Cardiol Young; 2023 Dec; 33(12):2616-2620. PubMed ID: 37078179
[TBL] [Abstract][Full Text] [Related]
8. Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence.
Xiao Q; Li Q; Zhang B; Yu W
Pediatr Surg Int; 2013 Jun; 29(6):575-81. PubMed ID: 23519547
[TBL] [Abstract][Full Text] [Related]
9. β-blockers in the treatment of periocular infantile hemangioma.
Al-Haddad C; El Salloukh NA; El Moussawi Z
Curr Opin Ophthalmol; 2019 Sep; 30(5):319-325. PubMed ID: 31394556
[TBL] [Abstract][Full Text] [Related]
10. Safety assessment during initiation and maintenance of propranolol therapy for infantile hemangiomas.
Babiak-Choroszczak L; Giżewska-Kacprzak K; Dawid G; Gawrych E; Bagłaj M
Adv Clin Exp Med; 2019 Mar; 28(3):375-384. PubMed ID: 30659785
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four-hour hospitalization for patients initiating systemic propranolol therapy for infantile hemangiomas--is it indicated?
Liu LS; Sokoloff D; Antaya RJ
Pediatr Dermatol; 2013; 30(5):554-60. PubMed ID: 23829941
[TBL] [Abstract][Full Text] [Related]
12. Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas.
Cushing SL; Boucek RJ; Manning SC; Sidbury R; Perkins JA
Otolaryngol Head Neck Surg; 2011 Jan; 144(1):78-84. PubMed ID: 21493392
[TBL] [Abstract][Full Text] [Related]
13. Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol.
Meyer-Mueller C; Nicholson C; Polcari I; Boull C; Maguiness S
Pediatr Dermatol; 2022 Mar; 39(2):255-259. PubMed ID: 35178750
[TBL] [Abstract][Full Text] [Related]
14. Propranolol is more effective than pulsed dye laser and cryosurgery for infantile hemangiomas.
Kagami S; Kuwano Y; Shibata S; Uwajima Y; Yamada D; Miyamoto A; Miyagawa T; Araki M; Takahashi K; Isomura S; Aozasa N; Masui Y; Yamamoto M; Inuzuka R; Katori T; Sato S
Eur J Pediatr; 2013 Nov; 172(11):1521-6. PubMed ID: 23812512
[TBL] [Abstract][Full Text] [Related]
15. Propranolol for the treatment of orbital infantile hemangiomas.
Fridman G; Grieser E; Hill R; Khuddus N; Bersani T; Slonim C
Ophthalmic Plast Reconstr Surg; 2011; 27(3):190-4. PubMed ID: 21283032
[TBL] [Abstract][Full Text] [Related]
16. [Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations].
Sánchez-Carpintero I; Ruiz-Rodriguez R; López-Gutiérrez JC
Actas Dermosifiliogr; 2011 Dec; 102(10):766-79. PubMed ID: 21774911
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study.
Nagata E; Kashiwagura Y; Okada E; Tanaka S; Sano S; Nishida M; Hayano S; Iwashima S; Hakamata A; Odagiri K; Inui N; Watanabe H; Umemura K; Uchida S
J Pharmacol Sci; 2022 Jun; 149(2):60-65. PubMed ID: 35512856
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study).
Chu DH; Castelo-Soccio L; Wan J; Gelfand JM; Shaddy RE; Shah KN; Perman MJ; Treat JR; Yan AC
Clin Pediatr (Phila); 2014 Oct; 53(11):1084-90. PubMed ID: 24849505
[TBL] [Abstract][Full Text] [Related]
19. Propranolol in infantile haemangioma: simplifying pretreatment monitoring.
El Ezzi O; Hohlfeld J; de Buys Roessingh A
Swiss Med Wkly; 2014 Mar; 144():w13943. PubMed ID: 24610228
[TBL] [Abstract][Full Text] [Related]
20. Interventions for infantile haemangiomas of the skin.
Novoa M; Baselga E; Beltran S; Giraldo L; Shahbaz A; Pardo-Hernandez H; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD006545. PubMed ID: 29667726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
